Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | BCL2L11 | O43521 | 1/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.34 |
| ▸ | GRN | P28799 | 1/20 | 0.33 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.33 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.32 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | ALPL | P05186 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18463773 | 0.83 | TOP2A (0.37) | TSHRSMN1; SMN2GAALMNA | |
| SCHEMBL24502139 | 0.82 | ELANE (0.42) | GABRA1GABRB2ELANEMEN1KMT2A | |
| SCHEMBL20706341 | 0.76 | ALDH1A1 (0.46) | GABRA1GABRB2ELANEMEN1KMT2A | |
| SCHEMBL16339195 | 0.74 | GABRA1 (0.44) | GABRA1GABRB2ELANEMEN1KMT2A | |
| SCHEMBL31557869 | 0.74 | GABRA1 (0.44) | GABRA1GABRB2ELANEMEN1KMT2A | |
| SCHEMBL28520886 | 0.74 | GABRA1 (0.44) | GABRA1GABRB2ELANEMEN1KMT2A | |
| SCHEMBL18463728 | 0.74 | PDE10A (0.37) | MEN1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL18463791 | 0.74 | BACE1 (0.51) | KMT2ACNR2LMNA | |
| SCHEMBL18463854 | 0.74 | PDE3B (0.36) | MEN1KMT2ASMN1; SMN2CYP2C9CYP2C19 | |
| SCHEMBL26488980 | 0.74 | GABRA1 (0.36) | GABRA1GABRB2ELANEMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10457699-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-10-29 | — | — | US | disclosed |
| US-20190051829-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190051829-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ORC3, BMP2, PPIP5K2 | GABRA1 3040/4885GABRB2 3008/4885ELANE 1012/4885 |
| US-10457699-B2 | Organic electroluminescent materials and devices | MLX, SSB, RPS4X | GABRA1 2848/4885GABRB2 3171/4885ELANE 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.